A detailed history of Gsb Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Gsb Wealth Management, LLC holds 6,896 shares of ABBV stock, worth $1.18 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
6,896
Previous 5,625 22.6%
Holding current value
$1.18 Million
Previous $964,000 41.18%
% of portfolio
0.35%
Previous 0.27%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$163.84 - $199.33 $208,240 - $253,348
1,271 Added 22.6%
6,896 $1.36 Million
Q2 2024

Jul 18, 2024

BUY
$154.79 - $180.76 $3,869 - $4,519
25 Added 0.45%
5,625 $964,000
Q1 2024

May 02, 2024

BUY
$159.82 - $182.1 $19,018 - $21,669
119 Added 2.17%
5,600 $1.02 Million
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $137 - $154
1 Added 0.02%
5,481 $849,000
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $9,484 - $10,980
71 Added 1.31%
5,480 $816,000
Q2 2023

Aug 08, 2023

BUY
$132.51 - $164.9 $13,118 - $16,325
99 Added 1.86%
5,409 $728,000
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $744,741 - $857,681
-5,150 Reduced 49.24%
5,310 $846,000
Q4 2022

Feb 16, 2023

SELL
$138.31 - $165.87 $219,359 - $263,069
-1,586 Reduced 13.17%
10,460 $1.69 Million
Q3 2022

Oct 18, 2022

BUY
$134.21 - $153.93 $11,676 - $13,391
87 Added 0.73%
12,046 $1.62 Million
Q2 2022

Jul 20, 2022

SELL
$137.62 - $174.96 $326,159 - $414,655
-2,370 Reduced 16.54%
11,959 $1.83 Million
Q1 2022

May 02, 2022

SELL
$131.98 - $163.75 $82,751 - $102,671
-627 Reduced 4.19%
14,329 $2.32 Million
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $365,906 - $462,977
3,406 Added 29.49%
14,956 $2.03 Million
Q3 2021

Oct 22, 2021

SELL
$106.4 - $120.78 $133,638 - $151,699
-1,256 Reduced 9.81%
11,550 $1.25 Million
Q2 2021

Jul 29, 2021

BUY
$105.21 - $117.21 $189,378 - $210,978
1,800 Added 16.35%
12,806 $1.44 Million
Q1 2021

Aug 11, 2021

SELL
$102.3 - $112.62 $31.3 Million - $34.4 Million
-305,600 Reduced 96.52%
11,006 $1.19 Million
Q1 2021

May 05, 2021

BUY
$102.3 - $112.62 $32.4 Million - $35.7 Million
316,606 New
316,606 $34.3 Million
Q4 2020

Feb 08, 2021

SELL
$80.49 - $108.67 $217,403 - $293,517
-2,701 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $63,474 - $79,420
-880 Reduced 24.57%
2,701 $239,000
Q4 2019

Feb 12, 2020

BUY
$72.13 - $90.25 $63,474 - $79,420
880 Added 32.58%
3,581 $317,000
Q3 2019

Nov 13, 2019

SELL
$62.98 - $75.72 $55,422 - $66,633
-880 Reduced 24.57%
2,701 $205,000
Q3 2019

Nov 12, 2019

BUY
$62.98 - $75.72 $225,531 - $271,153
3,581 New
3,581 $272,000
Q2 2019

Aug 09, 2019

SELL
$65.7 - $83.98 $177,455 - $226,829
-2,701 Closed
0 $0
Q3 2017

Nov 24, 2017

BUY
$69.85 - $89.22 $188,664 - $240,983
2,701
2,701 $240,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $304B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Gsb Wealth Management, LLC Portfolio

Follow Gsb Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsb Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gsb Wealth Management, LLC with notifications on news.